Vanda Pharmaceuticals | VNDA - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Eli Lilly USD 47B 745M 2026-09
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 596.57M 157.83M 2026-09
J&J USD 55.46B 562M 2026-09
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
Merck USD 27.73B 786M 2026-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Moderna USD 2.53B 139M 2026-06
Novartis USD 32.52B 1.15B 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Takeda JPY 2.6T 161B 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Veracyte USD 62.74M 6.62M 2026-06